Roll-over study for patients on a previous nilotinib Novartis study

• Research type

  Research Study

• Full title

  An open label, multicenter nilotinib roll-over protocol for patients who have completed a previous Novartis-sponsored nilotinib study and are judged by the investigator to benefit from continued nilotinib treatment.

• IRAS ID

  125716

• Contact name

  Charlotte Benson

• Contact email

  charlotte.benson@rmh.nhs.uk

• Eudract number

  2012-003902-28

• ISRCTN Number

  n/a

• REC name

  London - Harrow Research Ethics Committee

• REC reference

  13/LO/0332

• Date of REC Opinion

  22 Apr 2013

• REC opinion

  Further Information Favourable Opinion